For decades, the medical consensus was that moderate alcohol consumption — one glass of red wine per day — was protective for heart health. It was one of the few vice-as-medicine stories that seemed too good to be true. In 2026, the evidence allows a confident verdict: it was.
How the old evidence misled us
The "moderate drinking is healthy" narrative was based on observational studies that consistently found a J-shaped curve: non-drinkers had higher mortality than moderate drinkers, with heavy drinkers having the highest risk. The interpretation seemed straightforward — a glass of wine a day keeps the doctor away.
The problem was a fundamental methodological flaw called abstainer bias. The "non-drinker" group in these studies included people who had quit drinking due to illness, people on medications incompatible with alcohol, and people with health conditions that prevented them from drinking. These weren't healthy abstainers — they were sick people who couldn't drink. Comparing them to healthy moderate drinkers made alcohol look protective when it wasn't.
When researchers corrected for this bias — most notably in a landmark 2023 meta-analysis in JAMA Network Open covering 107 studies and nearly 5 million participants — the J-curve disappeared. Low-volume drinking (under about 25 g of alcohol a day, roughly two drinks) showed no significant reduction in mortality compared with lifetime non-drinkers, and the risk of death rose significantly from about 25 g a day in women and 45 g a day in men.
The Global Burden of Disease study (2018) put the level of drinking that minimizes health loss at zero. Its 2020 update found zero or near zero for adults under 40, and slightly more for some older adults.
What alcohol actually does to your body
Even at "moderate" levels (1–2 drinks per day), alcohol has measurable effects on several systems that a thorough check-up looks at:
- Liver: GGT is one of the most sensitive routine liver markers of alcohol exposure and tends to rise with regular drinking, although individual responses vary. ALT may follow with sustained consumption.
- Cancer: Alcohol is classified as a Group 1 carcinogen by the WHO. Even moderate consumption increases risk of breast cancer (about 7% per 10 g of alcohol — roughly one drink — per day), colorectal cancer, and esophageal cancer.
- Cardiovascular: While low-dose alcohol may slightly reduce coronary events, this is more than offset by increased risk of atrial fibrillation, hemorrhagic stroke, and cardiomyopathy.
- Metabolic: Alcohol impairs insulin sensitivity, increases triglycerides, contributes to visceral fat accumulation, and disrupts sleep architecture — even when you think it helps you sleep.
- Sleep: Alcohol is a sedative, not a sleep aid. It reduces REM sleep, increases sleep fragmentation, and worsens sleep apnea. It does help you fall asleep faster, but sleep in the second half of the night becomes more disrupted, so overall sleep quality suffers.
Why this matters in demanding jobs
Many professional cultures normalize regular alcohol consumption — business dinners, networking events, client entertainment, travel. A pattern of 2–3 drinks several nights per week is common and socially unremarkable. But it's not metabolically unremarkable.
Routine blood work often shows the fingerprints: mildly elevated GGT, triglycerides above optimal, disrupted sleep patterns, elevated uric acid. Each of these individually might be dismissed. Together, they form a pattern that often points to one thing — and it's usually not what the person expects to hear.
A reasonable approach
Moralizing about alcohol rarely helps. What helps is accurate evidence and your own numbers. If your GGT, triglycerides or uric acid are borderline, ask your doctor whether it makes sense to re-test after a few weeks of substantially reduced intake — for example, going from 14 drinks per week to 4. Seeing these values normalize is often more persuasive than any lecture. The data does the talking.
The bottom line: if you drink, understand that the old "one glass is good for you" story is dead. Corrected analyses find no meaningful health benefit even at low doses. There may be quality-of-life benefits that you value — and that's a legitimate personal choice. But make it with accurate information, not outdated science.
References
- Zhao J, et al. Association between daily alcohol intake and risk of all-cause mortality: a systematic review and meta-analyses. JAMA Netw Open. 2023;6(3):e236185.
- GBD 2020 Alcohol Collaborators. Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020. Lancet. 2022;400(10347):185-235.
- GBD 2016 Alcohol Collaborators. Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2018;392(10152):1015-1035.
- Biddinger KJ, et al. Association of habitual alcohol intake with risk of cardiovascular disease. JAMA Netw Open. 2022;5(3):e223849.
- Hamajima N, et al. Alcohol, tobacco and breast cancer — collaborative reanalysis of individual data from 53 epidemiological studies. Br J Cancer. 2002;87(11):1234-1245.
This article is general information and not individual medical advice. Decisions about tests and treatment belong in a conversation with your own physician.